Antibody data
- Antibody Data
 - Antigen structure
 - References [3]
 - Comments [0]
 - Validations
 - Western blot [1]
 - Immunohistochemistry [1]
 - Flow cytometry [1]
 
Submit
Validation data
Reference
Comment
Report error
- Product number
 - ABIN2843101 - Provider product page

 - Provider
 - antibodies-online
 - Product name
 - anti-Cell Division Cycle 45 Homolog (S. Cerevisiae) (CDC45) (AA 236-263), (Center) antibody
 - Antibody type
 - Polyclonal
 - Description
 - This antibody is purified through a protein A column, followed by peptide affinity purification.
 - Reactivity
 - Human
 - Host
 - Rabbit
 - Epitope
 - AA 236-263, Center
 - Antibody clone number
 - RB23958
 - Vial size
 - 80 μL
 - Storage
 - Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
 
Submitted references		Human CDT1 associates with CDC7 and recruits CDC45 to chromatin during S phase.
				
Irinotecan pharmacogenetics: influence of pharmacodynamic genes.
				
Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia.
				
		
	
			Ballabeni A, Zamponi R, Caprara G, Melixetian M, Bossi S, Masiero L, Helin K
The Journal of biological chemistry 2009 Jan 30;284(5):3028-36
		The Journal of biological chemistry 2009 Jan 30;284(5):3028-36
Irinotecan pharmacogenetics: influence of pharmacodynamic genes.
			Hoskins JM, Marcuello E, Altes A, Marsh S, Maxwell T, Van Booven DJ, Paré L, Culverhouse R, McLeod HL, Baiget M
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Mar 15;14(6):1788-96
		Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Mar 15;14(6):1788-96
Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia.
			Enjuanes A, Benavente Y, Bosch F, Martín-Guerrero I, Colomer D, Pérez-Alvarez S, Reina O, Ardanaz MT, Jares P, García-Orad A, Pujana MA, Montserrat E, de Sanjosé S, Campo E
Cancer research 2008 Dec 15;68(24):10178-86
		Cancer research 2008 Dec 15;68(24):10178-86
				No comments: Submit comment	
	
			
							
					Supportive validation
					
									
				
				- Submitted by
 - antibodies-online (provider)
 - Main image
 
- Experimental details
 - WB
 
							
					Supportive validation
					
									
				
				- Submitted by
 - antibodies-online (provider)
 - Main image
 
- Experimental details
 - IHC
 
							
					Supportive validation
					
									
				
		- Submitted by
 - antibodies-online (provider)
 - Main image
 
- Experimental details
 - FACS